You are here

Merck KGaA

Merck KGaA to pay over $3M to patients after drug formulation change-up triggered complaints

Endpoints

Thu, 03/17/22 - 11:27 pm

Merck restructures to strengthen CDMO business

Biopharma Reporter

Mon, 02/14/22 - 11:07 am

Merck KGaA shuffles organization to boost its CDMO operation as a top exec retires

Endpoints

Mon, 02/7/22 - 11:22 pm

Biopharma’s stock market winners of 2021 revealed

EP Vantage

Wed, 01/12/22 - 10:50 am

Moderna Therapeutics

Bicycle Therapeutics

Merck KGaA's venture arm is ready to make new investments, raising more than $675M to get things going

Endpoints

Wed, 12/8/21 - 10:41 am

venture capital

In quest to eliminate tropical diseases, Merck KGaA will submit anti-worming drug for approval in young children

Endpoints

Tue, 11/16/21 - 10:40 pm

schistosomiasis

tropical diseases

Biotech startup Marengo unveils $80M and a new way to get T cells to fight cancer

MedCity News

Mon, 11/8/21 - 11:00 am

Marengo Therapeutics

Apple Tree Partners

Merck KGgA venture arm bets on ‘next generation’ cancer therapeutics player

Biopharma Reporter

Tue, 10/5/21 - 10:53 am

venture capital

iOmx Therapeutics

GSK's $4.2B bet on Merck KGaA's cancer drug goes up in smoke as pharmas cut ties after series of flops

Fierce Biotech

Thu, 09/30/21 - 10:58 pm

biliary tract cancer

Merck KGaA entrusts secretive startup with a mid-stage cancer drug targeting master signaling pathway

Endpoints

Wed, 09/8/21 - 11:03 am

Merck KGaA’s targeted lung cancer drug tepotinib wins early access in UK

Pharmaforum

Thu, 07/15/21 - 12:29 pm

Merck partners with Innervia on bioelectronic therapy development

Pharma Times

Thu, 07/8/21 - 11:59 pm

Innvervia Bioelectronics

neurostimulation

Merck KGaA partners neuroloop on bioelectronic device for inflammation

Pharmaforum

Thu, 07/1/21 - 10:29 pm

neurostimulation

inflammatory diseases

Merck KGaA draws the curtain on newest lipid nanoparticle for mRNA vaccines, turbocharging its annual capacity

Endpoints

Wed, 05/26/21 - 11:39 pm

lipid nanoparticles

Forecast doubling of COVID-19 sales drives Merck KGaA to raise outlook

Biopharma Reporter

Mon, 05/17/21 - 10:47 am

MoonLake launches, licensing in Merck KGaA’s Cosentyx challenger sonelokimab

Pharmaforum

Tue, 05/4/21 - 10:37 am

MoonLake Immunotherapeutics

inflammatory disease

The retreat of corporate venture funding?

EP Vantage

Fri, 04/23/21 - 11:02 am

venture funding

venture capital

Boehringer Ingelheim

Bristol Myers Squibb

Merck KGaA lands rights to 3rd F-star oncology bispecific antibody

Fierce Biotech

Fri, 04/2/21 - 10:46 am

F-star Therapeutics

immuno-oncology

bispecific antibodies

GSK, Merck KGaA's BTC Drug Fails for Second Time This Year

BioSpace

Tue, 03/16/21 - 10:51 pm

metastatic biliary tract cancer

bintrafusp alfa

Merck KGaA foresees post-pandemic localization of biologics supply chains

Biopharma Reporter

Tue, 03/16/21 - 10:41 pm

Pages